Detalles de la búsqueda
1.
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study.
Breast Cancer Res Treat
; 149(1): 163-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25542269
2.
Expression of an activation antigen, Mo3e, associated with the cellular response to migration inhibitory factor by HL-60 promyelocytes undergoing monocyte-macrophage differentiation.
J Leukoc Biol
; 41(6): 492-9, 1987 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-3036984
3.
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic renal cell carcinoma: a phase II trial of the National Biotherapy Study Group.
Cancer Biother Radiopharm
; 12(1): 5-11, 1997 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-10851441
4.
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic melanoma: a phase II trial of the Cancer Biotherapy Research Group (formerly the National Biotherapy Study Group).
Cancer Biother Radiopharm
; 12(4): 249-55, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10851472
5.
Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
Cancer Biother Radiopharm
; 15(2): 175-83, 2000 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-10803323
6.
Regulation of human monocyte surface antigen expression. I. Up-modulation of Mo3e antigen expression on U-937 and HL-60 cells stimulated by pharmacologic activators of protein kinase C.
Blood
; 68(5): 1154-61, 1986 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-3768532
Resultados
1 -
6
de 6
1
Próxima >
>>